Search

Search Constraints

You searched for: Author/Creator Fox, Stephen B.

Search Results

11. Exploring the feasibility and utility of exome‐scale tumour sequencing in a clinical setting. Issue 7 (8th July 2018)

14. KRAS mutation testing of metastatic colorectal cancer in Australia: Where are we at?. Issue 3 (9th May 2014)

15. Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines. (6th March 2014)

16. Mammographically dense human breast tissue stimulates MCF10DCIS.com progression to invasive lesions and metastasis. Issue 1 (December 2016)

17. Molecular correlates of platinum response in human high‐grade serous ovarian cancer patient‐derived xenografts. Issue 3 (24th January 2014)

18. Novel RET Fusion RET-SEPTIN9 Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant Pheochromocytoma. (2021)

19. Precision oncology using a clinician‐directed, tailored approach to molecular profiling. Issue 1 (30th October 2017)

20. RAD21 COHESIN OVEREXPRESSION IS A PROGNOSTIC AND PREDICTIVE MARKER EXACERBATING POOR PROGNOSIS IN KRAS MUTANT COLORECTAL CARCINOMAS. (February 2015)